rs 67333 has been researched along with cisapride in 4 studies
Studies (rs 67333) | Trials (rs 67333) | Recent Studies (post-2010) (rs 67333) | Studies (cisapride) | Trials (cisapride) | Recent Studies (post-2010) (cisapride) |
---|---|---|---|---|---|
63 | 0 | 34 | 1,554 | 390 | 110 |
Protein | Taxonomy | rs 67333 (IC50) | cisapride (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.767 | |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 3.37 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.3 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0098 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.5923 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.07 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.1701 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.35 | |
Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | 2.69 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0098 | |
Insulin receptor | Rattus norvegicus (Norway rat) | 3.37 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.29 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 3.3827 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.26 | |
D | Rattus norvegicus (Norway rat) | 0.0065 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 3.6495 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0065 | |
D(1A) dopamine receptor | Homo sapiens (human) | 1.7 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0065 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0065 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 2.29 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0065 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.083 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0054 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.2597 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 3.6495 | |
5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 4.47 | |
5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 4.47 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0098 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.384 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.03 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.37 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.03 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.144 | |
5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.9 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0407 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.29 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.535 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.2536 | |
Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | 0.1701 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.994 | |
5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berque-Bestel, I; Dahmoune, Y; Donzeau-Gouge, P; Eftekhari, P; Fischmeister, R; Gastineau, M; Giner, M; Hoebeke, J; Langlois, M; Lezoualc'h, F; Mialet, J; Sicsic, S | 1 |
Berque-Bestel, I; Fischmeister, R; Langlois, M; Lezoualc'h, F; Mialet, J; Sicsic, S | 1 |
Fischmeister, R; Langlois, M | 1 |
Anzini, M; Cappelli, A; Caselli, G; Castriconi, F; Francini, CM; Giorgi, G; Giuliani, G; Grisci, G; Lanza, M; Mennuni, L; Paolino, M; Reale, A; Sabatini, C | 1 |
1 review(s) available for rs 67333 and cisapride
Article | Year |
---|---|
5-HT4 receptor ligands: applications and new prospects.
Topics: Animals; Benzamides; Benzimidazoles; Benzoates; Binding Sites; Cardiovascular Physiological Phenomena; Central Nervous System; Digestive System Physiological Phenomena; Humans; Indoles; Ketones; Ligands; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
3 other study(ies) available for rs 67333 and cisapride
Article | Year |
---|---|
Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
Topics: Alternative Splicing; Amino Acid Sequence; Animals; Antibody Specificity; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Glioma; Heart Atria; Humans; Molecular Sequence Data; Myocardium; Organ Specificity; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Reverse Transcriptase Polymerase Chain Reaction; Serotonin Antagonists; Serotonin Receptor Agonists | 2000 |
Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
Topics: Animals; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Protein Isoforms; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Structure-Activity Relationship; Sulfonamides | 2000 |
Development of subnanomolar-affinity serotonin 5-HT
Topics: | 2018 |